IL11 and myeloid sarcoma: Later studies found that IL11 is increased in the blood and cerebrospinal fluid of patients with early stage MS symptoms and also in patients with relapsing-remitting MS, where blood levels, likely from IL11-secreting CD4+ cells, increased further during periods of clinical deterioration [127].